Word: teste
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...Sandoz, as at most pharmaceutical companies in those days, new products came to market through a linear, three-step sequence. Researchers would seek out potential drugs. Development teams would test and refine them in hopes of winning regulatory approval. Finally, marketers would peddle the approved drugs to physicians. These steps were typically conducted in isolation, so developers would sometimes find out too late that a candidate drug had terrible side effects or could not be mass-produced economically. Or marketers would discover late in the process that there wasn't much demand for the new drug they would soon...
...sizable chunk of the estimated $24 billion that Americans spend to rejuvenate their faces and remove unwanted hair. Seeing synergies with its Neutrogena brand, J&J jumped into self-dermatology in 2004, signing an exploratory multiyear licensing deal with the $120 million company Palomar Medical Technologies to develop, test and commercialize light-based aesthetic devices that can treat wrinkles, cellulite and acne. "We have the potential to penetrate a good part of that market," says Palomar's chief financial officer, Paul Weiner--but so far no commercial product...
Another clue. So, I sent him off to the lab. A quick blood test made the diagnosis...
Sometime since his pre-op blood tests, Manuel had developed diabetes. Wound healing problems (though usually less dramatic than Manuel's) are often part of this disease, when the diabetes is uncontrolled - as it was in his case. The blood sugar test we did two weeks before the operation had been normal. It was quite high now. But Manuel started on insulin, stopped diuresing, got ruddy again and, to my great delight, closed up the cuts on his knee - all in the following week. He wasn't very happy about having to inject himself for the rest of his life...
...division of the Swiss drug giant Roche, will be ready to ship the first FDA-approved DNA diagnostic chips to labs in the U.S. The tiny gene detector, named AmpliChip, can help physicians assess how sensitive patients are to many commonly prescribed drugs. But will doctors order the test, which could cost $520? "We need to drive awareness," admits Heino von Prondzynski, global head of Roche Diagnostics. "Physicians usually don't know what to do with this information." Roche will also have to persuade insurers to cover the expense. It does have the stats on its side: adverse drug reactions...